GO:0043236 laminin binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043236 laminin binding is a molecular function defined as binding to a laminin, a major glycoprotein constituent of the basement membrane of cells.
• Laminins are heterotrimeric proteins composed of alpha, beta, and gamma chains that assemble into a cross-shaped structure and are essential for basement membrane organization.
• Laminin binding is mediated by cell surface receptors including integrins, dystroglycan, and other proteins, and is critical for cell adhesion, migration, and signaling.
• Dysregulation of laminin binding is implicated in cancer progression, including perineural invasion in prostate cancer and metastasis.
• Laminin binding also plays roles in stem cell differentiation and tissue engineering, with laminin fragments guiding cell fate.
• Research tools such as CRISPR knockout, knock-in, and overexpression models enable precise dissection of laminin binding mechanisms in health and disease.
Description
Laminin binding (GO:0043236) is a molecular function that refers to the binding to laminins, which are major glycoprotein constituents of the basement membrane of cells. Laminins are heterotrimeric proteins composed of alpha, beta, and gamma chains that assemble into a cross-shaped structure and are essential for basement membrane organization. This binding event is fundamental to cell-matrix interactions, influencing cell adhesion, migration, proliferation, and differentiation. The laminin family includes multiple isoforms, such as laminin-2 and laminin-4, which are recognized by specific binding partners. Laminin binding is mediated by cell surface receptors, including integrins and dystroglycan, which link the extracellular matrix to the cytoskeleton and signaling pathways. The importance of laminin binding extends to development, tissue homeostasis, and disease. For instance, the laminin-binding integrin alpha6beta1 is implicated in prostate cancer perineural invasion, and exogenous laminin exhibits a unique vascular pattern in the brain via binding to dystroglycan and integrins. Moreover, laminin fragments conjugated with perlecan's growth factor-binding domain can differentiate human induced pluripotent stem cells into skin-derived precursor cells. Understanding the molecular details of laminin binding is crucial for researchers in cell biology, cancer biology, and regenerative medicine. This article provides a comprehensive overview of the definition, mechanisms, key genes, research methods, and disease relevance of GO:0043236, optimized for both human readers and AI-driven retrieval.
laminin binding At A Glance
| GO ID | GO:0043236 |
|---|---|
| GO term | laminin binding |
| Ontology | molecular_function |
| Synonym | laminin-2 binding, laminin-4 binding |
| Definition | Binding to a laminin, a major glycoprotein constituent of the basement membrane of cells. |
| Major function | Mediates cell-matrix adhesion, signaling, and basement membrane assembly. |
| Related receptors | Integrins, dystroglycan, and other laminin-binding proteins. |
| Disease relevance | Cancer progression, perineural invasion, and stem cell differentiation. |
What Is GO:0043236?
According to the Gene Ontology, laminin binding (GO:0043236) is defined as the binding to a laminin, a major glycoprotein constituent of the basement membrane of cells. This molecular function encompasses the selective interaction between a protein or other molecule and any laminin isoform, including laminin-2 and laminin-4. It is a binding activity that occurs in the extracellular space or at the cell surface, where laminins are recognized by specific receptors. The term is used to annotate gene products that physically interact with laminins, thereby mediating cell adhesion, signaling, and structural organization of basement membranes.
Why Is laminin binding Important in Cell Biology?
Laminin binding is a fundamental molecular function that underpins cell-matrix communication, tissue architecture, and developmental processes. Laminins are essential components of basement membranes, and their binding to cell surface receptors such as integrins and dystroglycan regulates cell adhesion, migration, proliferation, and differentiation. Dysregulation of laminin binding is associated with various pathologies, including cancer invasion and metastasis, where laminin-binding integrins play opposing roles. For example, the integrin alpha6beta1 is a key mediator of prostate cancer perineural invasion. Additionally, laminin binding is exploited in regenerative medicine, as laminin fragments can direct stem cell differentiation. Thus, understanding laminin binding mechanisms is critical for both basic research and therapeutic development.
• Laminin binding is essential for basement membrane assembly and tissue integrity.
• It mediates cell adhesion and migration through receptors like integrins and dystroglycan.
• Laminin-binding integrins have opposing roles in cancer, influencing tumor progression and metastasis.
• The integrin alpha6beta1 is implicated in perineural invasion in prostate cancer.
• Laminin binding regulates stem cell differentiation and can be harnessed for regenerative medicine.
• Bacterial pathogens can exploit laminin binding for host colonization, as seen in Actinobacillus actinomycetemcomitans.
• Laminin N-terminal domain calcium binding affects laminin polymerization and function.
• Laminin binding is a target for therapeutic intervention in cancer and fibrosis.
• Research on laminin binding benefits from CRISPR models to dissect gene function.
• Understanding laminin binding aids in designing biomaterials for tissue engineering.
What Happens During laminin binding?
Laminin secretion and basement membrane assembly
In simple terms: Cells produce laminins and assemble them into a network that forms the basement membrane.
Laminins are synthesized and secreted by various cell types, including epithelial, endothelial, and muscle cells. They are heterotrimeric proteins composed of alpha, beta, and gamma chains that assemble into a cross-shaped structure. Once secreted, laminins self-assemble into a network through interactions involving their N-terminal domains, a process that can be modulated by calcium binding. This network serves as a scaffold for other basement membrane components, such as collagen IV, perlecan, and nidogen.
Receptor recognition and binding
In simple terms: Cell surface receptors recognize and bind to laminins, linking the cell to the matrix.
Laminin binding is mediated by specific cell surface receptors, including integrins (e.g., alpha6beta1, alpha3beta1, alpha7beta1) and dystroglycan. These receptors recognize distinct laminin isoforms and domains. For example, the integrin alpha6beta1 binds to laminin-2 and laminin-4 and is involved in prostate cancer perineural invasion. Dystroglycan binds to laminin via its glycosylated extracellular domain, and this interaction is important for brain vascular patterning. The binding specificity is determined by the laminin isoform and the receptor repertoire of the cell.
Cytoskeletal linkage and signaling
In simple terms: Binding triggers connections to the cytoskeleton and activates signaling pathways.
Upon laminin binding, receptors such as integrins cluster and recruit adaptor proteins (e.g., talin, paxillin) that link to the actin cytoskeleton, forming focal adhesions. This linkage provides mechanical support and transmits signals that regulate cell behavior. Integrin-mediated laminin binding activates signaling pathways including FAK, Src, and MAPK, influencing cell proliferation, survival, and migration. Dystroglycan binding to laminin also connects to the cytoskeleton via dystrophin and utrophin, and disruption of this linkage leads to muscular dystrophies.
Downstream effects on cell behavior
In simple terms: Laminin binding ultimately changes how cells grow, move, and specialize.
Laminin binding regulates diverse cellular processes, including adhesion, migration, proliferation, differentiation, and apoptosis. In cancer, laminin-binding integrins can promote or inhibit tumor progression depending on context. For instance, alpha6beta1 enhances perineural invasion in prostate cancer. In stem cells, laminin fragments conjugated with perlecan's growth factor-binding domain can direct differentiation into skin-derived precursor cells. Thus, laminin binding is a key determinant of cell fate and tissue organization.
Key Genes Involved in GO:0043236 laminin binding
The following genes encode proteins that bind laminins or are directly involved in laminin binding-mediated functions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITGA6 | Integrin alpha6 subunit; forms alpha6beta1 that binds laminin | Implicated in prostate cancer perineural invasion |
| ITGB1 | Integrin beta1 subunit; partners with alpha subunits to bind laminins | Key mediator of cell-matrix adhesion and signaling |
| ITGA3 | Integrin alpha3 subunit; forms alpha3beta1 laminin receptor | Roles in cancer and development |
| ITGA7 | Integrin alpha7 subunit; binds laminin in muscle | Muscular dystrophy and regeneration |
| DAG1 | Dystroglycan; binds laminin via glycosylation | Brain vascular patterning and muscular dystrophy |
| LAMA1 | Laminin alpha1 chain | Basement membrane assembly |
| LAMA2 | Laminin alpha2 chain (merosin) | Congenital muscular dystrophy |
| LAMA3 | Laminin alpha3 chain | Skin blistering diseases |
| LAMA4 | Laminin alpha4 chain | Angiogenesis and cancer |
| LAMA5 | Laminin alpha5 chain | Kidney and vascular development |
| LAMB1 | Laminin beta1 chain | Widespread basement membrane component |
| LAMB2 | Laminin beta2 chain | Neuromuscular junction and kidney |
| LAMC1 | Laminin gamma1 chain | Common to most laminins |
| LAMC2 | Laminin gamma2 chain | Epithelial adhesion and cancer |
| NID1 | Nidogen-1; links laminin to collagen IV | Basement membrane organization |
| HSPG2 | Perlecan; binds laminin and growth factors | Stem cell differentiation |
| ITGA2 | Integrin alpha2 subunit; binds collagen and laminin | Cell adhesion and signaling |
| ITGAV | Integrin alphaV subunit; can bind laminin in some contexts | Angiogenesis and cancer |
How Is laminin binding Regulated?
Laminin binding is regulated at multiple levels. The expression of laminin chains and their receptors is controlled transcriptionally and post-transcriptionally. For example, integrin expression can be modulated by growth factors and cytokines. Post-translational modifications, such as glycosylation of dystroglycan, are critical for laminin binding; defects in glycosylation lead to loss of binding and muscular dystrophy. Calcium ions regulate laminin self-assembly and binding properties through the N-terminal domain. Proteolytic processing of laminin chains can alter binding specificity and affinity. Additionally, the composition of the basement membrane and the presence of competing ligands influence laminin binding. Signaling pathways such as FAK and Src are activated downstream of laminin binding and can feedback to regulate receptor expression.
laminin binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ITGA6 | Prostate cancer perineural invasion | CRISPR knockout in prostate cancer cell lines; mouse xenograft |
| DAG1 | Muscular dystrophy (dystroglycanopathy) | Knockout or point mutation in muscle cells; zebrafish |
| LAMA2 | Congenital muscular dystrophy | Knockout mouse; patient-derived iPSCs |
| ITGB1 | Cancer progression and metastasis | Conditional knockout in mouse models; organoids |
| HSPG2 | Stem cell differentiation | Overexpression or knockout in iPSCs; differentiation assays |
Laminin binding in cancer progression
Laminin-binding integrins play complex and opposing roles in cancer. They can promote tumor cell adhesion, migration, and invasion, but in some contexts they act as tumor suppressors. The integrin alpha6beta1 is specifically implicated in perineural invasion in prostate cancer, a process associated with poor prognosis. Targeting laminin binding may therefore offer therapeutic opportunities, though context-dependent effects must be considered.
Laminin binding in muscular dystrophies
Dystroglycan, a laminin-binding protein, is critical for muscle integrity. Defective glycosylation of dystroglycan abolishes laminin binding and causes a group of muscular dystrophies known as dystroglycanopathies. Similarly, mutations in laminin alpha2 (merosin) cause congenital muscular dystrophy. These disorders highlight the importance of laminin binding for tissue stability.
Laminin binding in stem cell differentiation and regenerative medicine
Laminin binding can direct stem cell fate. For instance, laminin fragments conjugated with perlecan's growth factor-binding domain promote differentiation of human induced pluripotent stem cells into skin-derived precursor cells. This suggests that engineered laminin-based substrates can be used to control stem cell behavior for regenerative therapies.
Laminin binding in bacterial pathogenesis
Some bacterial pathogens exploit laminin binding to colonize host tissues. Actinobacillus actinomycetemcomitans, a periodontal pathogen, expresses a heat-modifiable outer membrane protein that binds laminin. This interaction may facilitate bacterial adherence to basement membranes and contribute to pathogenesis.
From laminin binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ITGA6 affect laminin binding and invasion? | CRISPR knockout of ITGA6 in cancer cell lines |
| Does a specific point mutation in DAG1 abolish laminin binding? | CRISPR point mutation knock-in in muscle cells |
| Can laminin binding be tracked in live cells? | Tagged knock-in of laminin receptors with fluorescent proteins |
| Does overexpression of LAMA1 enhance basement membrane assembly? | CRISPR overexpression in epithelial cells |
| What is the role of ITGB1 in development? | Conditional knockout mouse |
| Can laminin fragments direct stem cell differentiation? | Knock-in of perlecan domain into laminin; iPSC differentiation |
How to Study the laminin binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance | Binding affinity and kinetics | Receptor-laminin interaction analysis |
| Cell adhesion assay | Cell attachment to laminin | Functional assessment of laminin binding |
| CRISPR knockout screen | Genes required for laminin binding | Identification of novel regulators |
| Co-immunoprecipitation + MS | Protein complexes containing laminin | Discovery of laminin-binding partners |
| Immunofluorescence | Localization of laminin and receptors | Tissue and cell imaging |
| Glycosylation analysis | Post-translational modifications of dystroglycan | Diagnosis of dystroglycanopathies |
| Calcium binding assays | Calcium-dependent laminin assembly | Study of N-terminal domain function |
Biochemical binding assays
Solid-phase binding assays, surface plasmon resonance (SPR), and isothermal titration calorimetry (ITC) can measure the affinity and kinetics of laminin-receptor interactions. These methods use purified laminin or laminin fragments and recombinant receptors.
Cell adhesion assays
Cell adhesion assays on laminin-coated surfaces assess the ability of cells to bind laminin. This is often combined with blocking antibodies against specific integrins or dystroglycan to identify the receptors involved.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate laminin binding. Cells are incubated on laminin-coated plates, and bound cells are recovered and sequenced to identify enriched sgRNAs.
Imaging and proteomics
Immunofluorescence and live-cell imaging visualize laminin binding and receptor localization. Proteomics, such as co-immunoprecipitation coupled with mass spectrometry, identifies novel laminin-binding proteins and post-translational modifications.
How CRISPR Can Be Used to Study GO:0043236 laminin binding
Knockout
CRISPR knockout of genes encoding laminin receptors (e.g., ITGA6, ITGB1, DAG1) or laminin chains (e.g., LAMA1) can abolish laminin binding and reveal its functional consequences. For example, ITGA6 knockout reduces perineural invasion in prostate cancer models.
Point Mutation
Point mutations can be introduced to dissect specific residues required for laminin binding. For instance, mutating glycosylation sites in DAG1 or calcium-binding residues in laminin N-terminal domain can test their role in binding.
Knock-in
Knock-in of tagged laminin receptors (e.g., GFP-ITGA6) allows live-cell imaging of laminin binding dynamics. Knock-in of disease-associated mutations (e.g., in LAMA2) creates isogenic models for studying pathology.
Overexpression
Overexpression of laminin chains or receptors can enhance laminin binding and basement membrane assembly. This is useful for studying gain-of-function effects in cancer and tissue engineering.
How EDITGENE Supports laminin binding Research
Researchers studying laminin binding-related genes often need to determine whether a candidate gene is causally involved in cell adhesion, migration, or disease progression. EDITGENE provides comprehensive CRISPR gene editing services to create precise cellular and animal models, enabling functional validation of laminin binding mechanisms.
Contact EDITGENE today to design your custom CRISPR model for laminin binding research.
Frequently Asked Questions About laminin binding
What is laminin binding?
Laminin binding (GO:0043236) is a molecular function defined as binding to a laminin, a major glycoprotein constituent of the basement membrane of cells.
What genes are involved in laminin binding?
Key genes include ITGA6, ITGB1, ITGA3, ITGA7, DAG1, and laminin chain genes such as LAMA1, LAMA2, LAMB1, and LAMC1.
What is the function of laminin binding?
Laminin binding mediates cell adhesion, migration, proliferation, differentiation, and basement membrane assembly.
How is laminin binding studied?
Common methods include cell adhesion assays, surface plasmon resonance, CRISPR screens, and immunofluorescence.
What diseases are associated with laminin binding?
Dysregulation of laminin binding is linked to cancer progression, muscular dystrophies, and bacterial pathogenesis.
What is the role of integrin alpha6beta1 in laminin binding?
Integrin alpha6beta1 is a major laminin receptor and is implicated in prostate cancer perineural invasion.
How does dystroglycan bind to laminin?
Dystroglycan binds laminin via its glycosylated extracellular domain, and this interaction is critical for muscle and brain function.
Can laminin binding be targeted therapeutically?
Yes, laminin-binding integrins are being explored as therapeutic targets in cancer, though context-dependent effects exist.
What is the role of calcium in laminin binding?
Calcium binding to the laminin N-terminal domain regulates laminin self-assembly and polymerization.
How can CRISPR be used to study laminin binding?
CRISPR knockout, knock-in, and overexpression models allow precise manipulation of laminin-binding genes to study their function in health and disease.
Conclusion
Laminin binding (GO:0043236) is a fundamental molecular function that governs cell-matrix interactions and is critical for development, tissue homeostasis, and disease. The interaction between laminins and their receptors, such as integrins and dystroglycan, regulates diverse cellular behaviors and is implicated in cancer, muscular dystrophies, and stem cell differentiation. Advances in CRISPR gene editing and other technologies continue to unravel the complexities of laminin binding, offering new avenues for therapeutic intervention. EDITGENE provides the tools and expertise to accelerate this research.
References
- 1. Ramovs V et al.. 2017. The opposing roles of laminin-binding integrins in cancer.. Matrix Biol 57-58:213-243 PMID: 27562932
- 2. Sroka IC et al.. 2010. The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion.. J Cell Physiol 224(2):283-8 PMID: 20432448
- 3. Alugupalli KR et al.. 1996. Laminin binding to a heat-modifiable outer membrane protein of Actinobacillus actinomycetemcomitans.. Oral Microbiol Immunol 11(5):326-31 PMID: 9028258
- 4. Sugiyama-Nakagiri Y et al.. 2023. Laminin fragments conjugated with perlecan's growth factor-binding domain differentiate human induced pluripotent stem cells into skin-derived precursor cells.. Sci Rep 13(1):14556 PMID: 37666868
- 5. Aumailley M. 2013. The laminin family.. Cell Adh Migr 7(1):48-55 PMID: 23263632
- 6. Timpl R et al.. 1994. The laminins.. Matrix Biol 14(4):275-81 PMID: 7827749
- 7. Ruan J et al.. 2022. Exogenous laminin exhibits a unique vascular pattern in the brain via binding to dystroglycan and integrins.. Fluids Barriers CNS 19(1):97 PMID: 36463265
- 8. Legare S et al.. 2024. Identifying the molecular basis of Laminin N-terminal domain Ca(2+) binding using a hybrid approach.. Biophys J 123(16):2422-2430 PMID: 38851889
